Ceapro’s CEO and president to step down
In the mean time, Gilles Gagnon, an independent director of the company will act as president and CEO during the search period for a new CEO.

In the mean time, Gilles Gagnon, an independent director of the company will act as president and CEO during the search period for a new CEO.

The 40mg dose did not demonstrate increased efficacy in reducing the relapse rate; however, the higher dose maintained the favorable safety and tolerability profile of Copaxone 20mg. Approximately

After this transaction Probio will have four modern production facilities in three countries and will have pharmaceutical and nutraceutical capabilities in soft gel encapsulations, powders, liquid and tablet

InTouch’s StrokeRespond is part of an initiative to develop telestroke networks to enhance stroke care. In addition to the development of this new feature for the stroke community,

Before joining Axolotl, Ms Somer served as principal of CBS Communications, a boutique marketing communications firm. Previous successes include director of marketing and public relations for Care Fusion,

As a result of this acquisition, Vitrolife owns 60% of the company, with an option to acquire a further 10% within six months. Magnus Nilsson, CEO of Vitrolife,

This third party testing was performed as part of an ongoing investigative effort to further identify mechanisms by which the Eniva Vibe nutraceutical impacts human health. The research

LinkMed said that the acquisition will further strengthen its position in the transplantation sector and is strategically important in that it complements its portfolio company AbSorber and its

As per the terms of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to Viralliance to use the ABL patent portfolio for guiding and ranking

Each investment unit consists of a share of common stock, two series of common stock purchase warrants to purchase 0.5 share of common stock respectively. Approximately $2.5 million